Mixed
Bariatric surgery (gastric bypass, sleeve gastrectomy, or gastric banding) leads to net cost savings for healthcare systems over a lifetime horizon compared to conservative medical management, primarily through the reduction of long-term complications from type 2 diabetes and cardiovascular disease.
For patients with severe obesity, bariatric surgery is not just a weight-loss tool but a cost-saving medical intervention over a lifetime. It significantly reduces the risk of diabetes and heart disease, leading to net financial savings for the healthcare system and improved quality of life. Delaying surgery, especially for those with diabetes or very high BMI, results in higher long-term costs and worse health outcomes.
Bariatric surgery was cost saving in comparison with conservative management. It also led to a substantial reduction in lifetime risk of events: from a 16 % reduction in the risk of transient ischaemic attacks to a 62 % reduction in the incidence of type 2 diabetes. Over a lifetime, surgery led to savings of €8408 and generated an additional 0.8 years of life and 4.1 quality-adjusted life years (QALYs) per patient
Why this rating
This is a decision-analytic model (Markov process) based on registry data and literature, not a primary Randomized Controlled Trial (RCT), though it uses high-quality registry data (SOREG, SOS).
Source
Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model
Oleg Borisenko et al. · Obesity Surgery · 2015
DOI 10.1007/s11695-014-1567-5
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →